{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T19:12:05Z","timestamp":1793301125923,"version":"4.5.0"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T00:00:00Z","timestamp":1594339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T00:00:00Z","timestamp":1594339200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100001253","name":"Multiple Myeloma Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001253","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005189","name":"Leukemia and Lymphoma Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005189","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1038\/s41375-020-0921-y","type":"journal-article","created":{"date-parts":[[2020,7,10]],"date-time":"2020-07-10T13:03:38Z","timestamp":1594386218000},"page":"2887-2897","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":100,"title":["Genome instability in multiple myeloma"],"prefix":"10.1038","volume":"34","author":[{"given":"Carl Jannes","family":"Neuse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver C.","family":"Lomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Schliemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu Jia","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salomon","family":"Manier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4652-5449","authenticated-orcid":false,"given":"Mark","family":"Bustoros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7361-3092","authenticated-orcid":false,"given":"Irene M.","family":"Ghobrial","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,10]]},"reference":[{"key":"921_CR1","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1056\/NEJMra1011442","volume":"364","author":"A Palumbo","year":"2011","unstructured":"Palumbo A, Anderson K. Multiple myeloma. N Engl J Med. 2011;364:1046\u201360.","journal-title":"N Engl J Med"},{"key":"921_CR2","unstructured":"Howlader Nea. SEER cancer statistics review. SEER. 1975\u20132013. https:\/\/seer.cancer.gov\/csr\/1975_2013\/."},{"key":"921_CR3","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nrclinonc.2016.122","volume":"14","author":"S Manier","year":"2017","unstructured":"Manier S, Salem KZ, Park J, Landau DA, Getz G, Ghobrial IM. Genomic complexity of multiple myeloma and its clinical implications. Nat Rev Clin Oncol. 2017;14:100\u201313.","journal-title":"Nat Rev Clin Oncol"},{"key":"921_CR4","doi-asserted-by":"crossref","first-page":"5412","DOI":"10.1182\/blood-2008-12-194241","volume":"113","author":"O Landgren","year":"2009","unstructured":"Landgren O, Kyle RA, Pfeiffer RM, Katzmann JA, Caporaso NE, Hayes RB, et al. Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study. Blood. 2009;113:5412\u20137.","journal-title":"Blood"},{"key":"921_CR5","doi-asserted-by":"publisher","unstructured":"Bakhoum SF, Landau DA. Chromosomal instability as a driver of tumor heterogeneity and evolution. Cold Spring Harb Perspect Med. 2017;7:a029611. https:\/\/doi.org\/10.1101\/cshperspect.a029611.","DOI":"10.1101\/cshperspect.a029611"},{"key":"921_CR6","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/nrm2858","volume":"11","author":"S Negrini","year":"2010","unstructured":"Negrini S, Gorgoulis VG, Halazonetis TD. Genomic instability\u2014an evolving hallmark of cancer. Nat Rev Mol Cell Biol. 2010;11:220\u20138.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"921_CR7","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nrclinonc.2017.198","volume":"15","author":"L Sansregret","year":"2018","unstructured":"Sansregret L, Vanhaesebroeck B, Swanton C. Determinants and clinical implications of chromosomal instability in cancer. Nat Rev Clin Oncol. 2018;15:139\u201350.","journal-title":"Nat Rev Clin Oncol"},{"key":"921_CR8","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/25292","volume":"396","author":"C Lengauer","year":"1998","unstructured":"Lengauer C, Kinzler KW, Vogelstein B. Genetic instability in human cancers. Nature. 1998;396:643\u20139.","journal-title":"Nature."},{"key":"921_CR9","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1038\/ng.2762","volume":"45","author":"G Ciriello","year":"2013","unstructured":"Ciriello G, Miller ML, Aksoy BA, Senbabaoglu Y, Schultz N, Sander C. Emerging landscape of oncogenic signatures across human cancers. Nat Genet. 2013;45:1127.","journal-title":"Nat Genet."},{"key":"921_CR10","doi-asserted-by":"crossref","first-page":"302","DOI":"10.3389\/fonc.2013.00302","volume":"3","author":"AV Roschke","year":"2013","unstructured":"Roschke AV, Rozenblum E. Multi-layered cancer chromosomal instability phenotype. Front Oncol. 2013;3:302.","journal-title":"Front Oncol"},{"key":"921_CR11","doi-asserted-by":"publisher","unstructured":"Thompson LL, Jeusset LM, Lepage CC, McManus KA-O. Evolving therapeutic strategies to exploit chromosome instability in cancer. Cancers. 2017;9:151. https:\/\/doi.org\/10.3390\/cancers9110151.","DOI":"10.3390\/cancers9110151"},{"key":"921_CR12","doi-asserted-by":"crossref","first-page":"224","DOI":"10.18632\/oncotarget.476","volume":"3","author":"MC Casimiro","year":"2012","unstructured":"Casimiro MC, Pestell RG. Cyclin d1 induces chromosomal instability. Oncotarget. 2012;3:224\u20135.","journal-title":"Oncotarget."},{"key":"921_CR13","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/nature08136","volume":"460","author":"NJ Ganem","year":"2009","unstructured":"Ganem NJ, Godinho SA, Pellman D. A mechanism linking extra centrosomes to chromosomal instability. Nature. 2009;460:278\u201382. (1476-4687 (Electronic))","journal-title":"Nature."},{"key":"921_CR14","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1016\/j.cub.2009.09.055","volume":"19","author":"SF Bakhoum","year":"2009","unstructured":"Bakhoum SF, Genovese G, Compton DA. Deviant kinetochore microtubule dynamics underlie chromosomal instability. Curr Biol. 2009;19:1937\u201342.","journal-title":"Curr Biol"},{"key":"921_CR15","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/nature11935","volume":"494","author":"RA Burrell","year":"2013","unstructured":"Burrell RA, McClelland SE, Endesfelder D, Groth P, Weller MC, Shaikh N, et al. Replication stress links structural and numerical cancer chromosomal instability. Nature 2013;494:492\u20136.","journal-title":"Nature"},{"key":"921_CR16","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/nature10802","volume":"482","author":"K Crasta","year":"2012","unstructured":"Crasta K, Ganem NJ, Dagher R, Lantermann AB, Ivanova EV, Pan Y, et al. DNA breaks and chromosome pulverization from errors in mitosis. Nature 2012;482:53\u20138.","journal-title":"Nature"},{"key":"921_CR17","doi-asserted-by":"crossref","first-page":"4798","DOI":"10.1200\/JCO.2007.13.8545","volume":"26","author":"O Decaux","year":"2008","unstructured":"Decaux O, Lode L, Magrangeas F, Charbonnel C, Gouraud W, Jezequel P, et al. Prediction of survival in multiple myeloma based on gene expression profiles reveals cell cycle and chromosomal instability signatures in high-risk patients and hyperdiploid signatures in low-risk patients: a study of the Intergroupe Francophone du Myelome. J Clin Oncol. 2008;26:4798\u2013805.","journal-title":"J Clin Oncol"},{"key":"921_CR18","doi-asserted-by":"crossref","unstructured":"Chung TH, Mulligan G, Fonseca R, Chng WJ. A novel measure of chromosome instability can account for prognostic difference in multiple myeloma. PLoS ONE. 2013;8.","DOI":"10.1371\/journal.pone.0066361"},{"key":"921_CR19","first-page":"67","volume":"35","author":"T Boveri","year":"1903","unstructured":"Boveri T. \u00dcber mehrpolige Mitosen als Mittel zur Analyse des Zellkerns [On multipolar mitosis as a means of analysis of the cell nucleus]. Verh Phys Med Ges Wurzbg. 1903;35:67\u201390.","journal-title":"Verh Phys Med Ges Wurzbg"},{"key":"921_CR20","first-page":"3854","volume":"55","author":"J Drach","year":"1995","unstructured":"Drach J, Schuster J, Nowotny H, Angerler J, Rosenthal F, Fiegl M, et al. Multiple myeloma: high incidence of chromosomal aneuploidy as detected by interphase fluorescence in situ hybridization. Cancer Res. 1995;55:3854\u20139.","journal-title":"Cancer Res."},{"key":"921_CR21","volume":"10","author":"F Maura","year":"2019","unstructured":"Maura F, Bolli N, Angelopoulos N, Dawson KJ, Leongamornlert D, Martincorena I, et al. Genomic landscape and chronological reconstruction of driver events in multiple myeloma. Nat Commun. 2019;10:3835.","journal-title":"Nat Commun."},{"key":"921_CR22","unstructured":"Bustoros M, Sklavenitis-Pistofidis R, Park J, Redd R, Zhitomirsky B, Dunford AJ, et al. Genomic profiling of smoldering multiple myeloma identifies patients at a high risk of disease progression. J Clin Oncol. 2020:Jco2000437. [Epub ahead of print]"},{"key":"921_CR23","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1007\/s00432-018-2732-3","volume":"144","author":"J Mei","year":"2018","unstructured":"Mei J, Zhai Y, Li H, Li F, Zhou X, Song P, et al. Prognostic impact of hyperdiploidy in multiple myeloma patients with high-risk cytogenetics: a pilot study in China. J Cancer Res Clin Oncol. 2018;144:2263\u201373.","journal-title":"J Cancer Res Clin Oncol"},{"key":"921_CR24","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ccell.2016.12.004","volume":"31","author":"JM Sheltzer","year":"2017","unstructured":"Sheltzer JM, Ko JH, Replogle JM, Habibe Burgos NC, Chung ES, Meehl CM, et al. Single-chromosome gains commonly function as tumor suppressors. Cancer Cell. 2017;31:240\u201355.","journal-title":"Cancer Cell."},{"key":"921_CR25","volume":"6","author":"BA Walker","year":"2015","unstructured":"Walker BA, Wardell CP, Murison A, Boyle EM, Begum DB, Dahir NM, et al. APOBEC family mutational signatures are associated with poor prognosis translocations in multiple myeloma. Nat Commun. 2015;6:6997.","journal-title":"Nat Commun."},{"key":"921_CR26","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1007\/s00277-014-2057-5","volume":"93","author":"S Oh","year":"2014","unstructured":"Oh S, Koo Dh Fau - Kwon M-J, Kwon Mj Fau - Kim K, Kim K, Fau - Suh C, Suh C, et al. Chromosome 13 deletion and hypodiploidy on conventional cytogenetics are robust prognostic factors in Korean multiple myeloma patients: web-based multicenter registry study. Ann Hematol. 2014;93:1353\u201361.","journal-title":"Ann Hematol."},{"key":"921_CR27","volume":"8","author":"P Wu","year":"2017","unstructured":"Wu P, Li T, Li R, Jia L, Zhu P, Liu Y, et al. 3D genome of multiple myeloma reveals spatial genome disorganization associated with copy number variations. Nat Commun. 2017;8:1937.","journal-title":"Nat Commun."},{"key":"921_CR28","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/nature13986","volume":"515","author":"BD Pope","year":"2014","unstructured":"Pope BD, Ryba T, Dileep V, Yue F, Wu W, Denas O, et al. Topologically associating domains are stable units of replication-timing regulation. Nature. 2014;515:402.","journal-title":"Nature."},{"key":"921_CR29","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1182\/blood-2010-04-279596","volume":"116","author":"BA Walker","year":"2010","unstructured":"Walker BA, Leone PE, Chiecchio L, Dickens NJ, Jenner MW, Boyd KD, et al. A compendium of myeloma-associated chromosomal copy number abnormalities and their prognostic value. Blood. 2010;116:e56\u201365.","journal-title":"Blood"},{"key":"921_CR30","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nrc.2017.63","volume":"17","author":"C Pawlyn","year":"2017","unstructured":"Pawlyn C, Morgan GJ. Evolutionary biology of high-risk multiple myeloma. Nat Rev Cancer. 2017;17:543.","journal-title":"Nat Rev Cancer"},{"key":"921_CR31","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1365-2141.2006.06325.x","volume":"135","author":"H Chang","year":"2006","unstructured":"Chang H, Qi X, Trieu Y, Xu W, Reader JC, Ning Y, et al. Multiple myeloma patients with CKS1B gene amplification have a shorter progression-free survival post-autologous stem cell transplantation. Br J Haematol. 2006;135:486\u201391.","journal-title":"Br J Haematol"},{"key":"921_CR32","doi-asserted-by":"crossref","first-page":"3911","DOI":"10.1200\/JCO.2014.59.1503","volume":"33","author":"BA Walker","year":"2015","unstructured":"Walker BA, Boyle EM, Wardell CP, Murison A, Begum DB, Dahir NM, et al. Mutational spectrum, copy number changes, and outcome: results of a sequencing study of patients with newly diagnosed myeloma. J Clin Oncol. 2015;33:3911\u201320.","journal-title":"J Clin Oncol"},{"key":"921_CR33","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1182\/blood.V91.5.1732","volume":"91","author":"JR Sawyer","year":"1998","unstructured":"Sawyer JR, Tricot G, Mattox S, Jagannath S, Barlogie B. Jumping translocations of chromosome 1q in multiple myeloma: evidence for a mechanism involving decondensation of pericentromeric heterochromatin. Blood. 1998;91:1732\u201341.","journal-title":"Blood."},{"key":"921_CR34","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1158\/2159-8290.CD-17-0841","volume":"8","author":"HB Maganti","year":"2018","unstructured":"Maganti HB, Jrade H, Cafariello C, Manias Rothberg JL, Porter CJ, Yockell-Leli\u00e8vre J, et al. Targeting the MTF2\u2013MDM2 axis sensitizes refractory acute myeloid leukemia to chemotherapy. Cancer Discov. 2018;8:1376\u201389.","journal-title":"Cancer Discov."},{"key":"921_CR35","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1182\/blood-2006-08-040410","volume":"109","author":"H Avet-Loiseau","year":"2007","unstructured":"Avet-Loiseau H, Attal M, Moreau P, Charbonnel C, Garban F, Hulin C, et al. Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myelome. Blood. 2007;109:3489\u201395.","journal-title":"Blood."},{"key":"921_CR36","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1182\/blood.V94.8.2583.420a05_2583_2589","volume":"94","author":"H Avet-Loiseau","year":"1999","unstructured":"Avet-Loiseau H, Li JY, Morineau N, Facon T, Brigaudeau C, Harousseau JL, et al. Monosomy 13 is associated with the transition of monoclonal gammopathy of undetermined significance to multiple myeloma. Intergroupe Francophone du Myelome. Blood. 1999;94:2583\u20139.","journal-title":"Blood."},{"key":"921_CR37","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2017.12","volume":"7","author":"SS Chavan","year":"2017","unstructured":"Chavan SS, He J, Tytarenko R, Deshpande S, Patel P, Bailey M, et al. Bi-allelic inactivation is more prevalent at relapse in multiple myeloma, identifying RB1 as an independent prognostic marker. Blood Cancer J. 2017;7:e535-e.","journal-title":"Blood Cancer J"},{"key":"921_CR38","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/s41375-018-0196-8","volume":"33","author":"BA Walker","year":"2019","unstructured":"Walker BA, Mavrommatis K, Wardell CP, Ashby TC, Bauer M, Davies F, et al. A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis. Leukemia. 2019;33:159\u201370.","journal-title":"Leukemia."},{"key":"921_CR39","doi-asserted-by":"crossref","unstructured":"Lenz G, Pasqualucci L, Klapper W, Klein U, Silva NSD, Zha S, et al. Malignant Lymphomas. 1st edn. Berlin\/Boston: De Gruyter; 2016.","DOI":"10.1515\/9783110366914"},{"key":"921_CR40","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1146\/annurev.immunol.23.021704.115830","volume":"24","author":"D Jung","year":"2006","unstructured":"Jung D, Giallourakis C, Mostoslavsky R, Alt FW. Mechanism and control of V(D)J recombination at the immunoglobulin heavy chain locus. Annu Rev Immunol. 2006;24:541\u201370.","journal-title":"Annu Rev Immunol"},{"key":"921_CR41","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.dnarep.2006.05.013","volume":"5","author":"MR Lieber","year":"2006","unstructured":"Lieber MR, Yu K, Raghavan SC. Roles of nonhomologous DNA end joining, V(D)J recombination, and class switch recombination in chromosomal translocations. DNA Repair. 2006;5:1234\u201345.","journal-title":"DNA Repair"},{"key":"921_CR42","unstructured":"Max EE. Immunoglobulins: molecular genetics. In: Paul WE, editor. Philadelphia, PA: Lippincott-Raven; 1999."},{"key":"921_CR43","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0065-2776(06)94003-6","volume":"94","author":"A Ramiro","year":"2007","unstructured":"Ramiro A, Reina San-Martin B, McBride K, Jankovic M, Barreto V, Nussenzweig A, et al. The role of activation-induced deaminase in antibody diversification and chromosome translocations. Adv Immunol. 2007;94:75\u2013107.","journal-title":"Adv Immunol"},{"key":"921_CR44","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/hon.688","volume":"20","author":"JA Fenton","year":"2002","unstructured":"Fenton JA, Pratt G, Rawstron AC, Morgan GJ. Isotype class switching and the pathogenesis of multiple myeloma. Hematol Oncol.2002;20:75\u201385.","journal-title":"Hematol Oncol."},{"key":"921_CR45","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1182\/blood.V90.2.526","volume":"90","author":"K Nishida","year":"1997","unstructured":"Nishida K, Tamura A, Nakazawa N, Ueda Y, Abe T, Matsuda F, et al. The Ig heavy chain gene is frequently involved in chromosomal translocations in multiple myeloma and plasma cell leukemia as detected by in situ hybridization. Blood. 1997;90:526\u201334.","journal-title":"Blood."},{"key":"921_CR46","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s12185-013-1291-2","volume":"97","author":"M Chesi","year":"2013","unstructured":"Chesi M, Bergsagel PL. Molecular pathogenesis of multiple myeloma: basic and clinical updates. Int J Hematol. 2013;97:313\u201323.","journal-title":"Int J Hematol"},{"key":"921_CR47","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1182\/blood-2018-03-840132","volume":"132","author":"BA Walker","year":"2018","unstructured":"Walker BA, Mavrommatis K, Wardell CP, Ashby TC, Bauer M, Davies FE, et al. Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma. Blood. 2018;132:587\u201397.","journal-title":"Blood."},{"key":"921_CR48","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/nrc2231","volume":"8","author":"N Meyer","year":"2008","unstructured":"Meyer N, Penn LZ. Reflecting on 25 years with MYC. Nat Rev Cancer. 2008;8:976\u201390.","journal-title":"Nat Rev Cancer"},{"key":"921_CR49","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1038\/leu.2014.70","volume":"28","author":"M Affer","year":"2014","unstructured":"Affer M, Chesi M, Chen WD, Keats JJ, Demchenko YN, Tamizhmani K, et al. Promiscuous MYC locus rearrangements hijack enhancers but mostly super-enhancers to dysregulate MYC expression in multiple myeloma. Leukemia. 2014;28:1725.","journal-title":"Leukemia."},{"key":"921_CR50","doi-asserted-by":"crossref","first-page":"6997.","DOI":"10.1038\/ncomms7997","volume":"6","author":"BA-O Walker","year":"2015","unstructured":"Walker BA-O, Wardell CP, Murison A, Boyle EM, Begum DB, Dahir NM, et al. APOBEC family mutational signatures are associated with poor prognosis translocations in multiple myeloma. Nat Commun. 2015;6:6997.","journal-title":"Nat Commun"},{"key":"921_CR51","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.bbagrm.2014.03.013","volume":"1849","author":"G Bretones","year":"2015","unstructured":"Bretones G, Delgado MD, Leon J. Myc and cell cycle control. Biochim Biophys Acta. 2015;1849:506\u201316.","journal-title":"Biochim Biophys Acta"},{"key":"921_CR52","doi-asserted-by":"crossref","first-page":"3940","DOI":"10.1073\/pnas.96.7.3940","volume":"96","author":"DW Felsher","year":"1999","unstructured":"Felsher DW, Bishop JM. Transient excess of MYC activity can elicit genomic instability and tumorigenesis. Proc Natl Acad Sci USA. 1999;96:3940\u20134.","journal-title":"Proc Natl Acad Sci USA"},{"key":"921_CR53","doi-asserted-by":"crossref","first-page":"a014373","DOI":"10.1101\/cshperspect.a014373","volume":"4","author":"A Kuzyk","year":"2014","unstructured":"Kuzyk A, Mai S. c-MYC-induced genomic instability. Cold Spring Harb Perspect Med. 2014;4:a014373.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"921_CR54","doi-asserted-by":"publisher","unstructured":"Kumari A, Folk WP, Sakamuro D. The dual roles of MYC in genomic instability and cancer chemoresistance. Genes. 2017;8:158. https:\/\/doi.org\/10.3390\/genes8060158.","DOI":"10.3390\/genes8060158"},{"key":"921_CR55","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/j.cell.2015.11.054","volume":"163","author":"J Maciejowski","year":"2015","unstructured":"Maciejowski J, Li Y, Bosco N, Campbell PJ, de Lange T. Chromothripsis and kataegis induced by telomere crisis. Cell. 2015;163:1641\u201354.","journal-title":"Cell."},{"key":"921_CR56","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.cell.2013.06.007","volume":"154","author":"EM Hatch","year":"2013","unstructured":"Hatch EM, Fischer AH, Deerinck TJ, Hetzer MW. Catastrophic nuclear envelope collapse in cancer cell micronuclei. Cell. 2013;154:47\u201360.","journal-title":"Cell."},{"key":"921_CR57","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nature14493","volume":"522","author":"C-Z Zhang","year":"2015","unstructured":"Zhang C-Z, Spektor A, Cornils H, Francis JM, Jackson EK, Liu S, et al. Chromothripsis from DNA damage in micronuclei. Nature. 2015;522:179.","journal-title":"Nature."},{"key":"921_CR58","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cell.2010.11.055","volume":"144","author":"PJ Stephens","year":"2011","unstructured":"Stephens PJ, Greenman CD, Fu B, Yang F, Bignell GR, Mudie LJ, et al. Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell. 2011;144:27\u201340.","journal-title":"Cell"},{"key":"921_CR59","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1182\/blood-2011-03-344069","volume":"118","author":"F Magrangeas","year":"2011","unstructured":"Magrangeas F, Avet-Loiseau H, Munshi NC, Minvielle S. Chromothripsis identifies a rare and aggressive entity among newly diagnosed multiple myeloma patients. Blood. 2011;118:675\u20138.","journal-title":"Blood."},{"key":"921_CR60","doi-asserted-by":"crossref","unstructured":"Rustad EH, Yellapantula VD, Glodzik D, Maclachlan KH, Diamond B, Boyle EM, et al. Revealing the impact of recurrent and rare structural variants in multiple myeloma. 2019. https:\/\/www.biorxiv.org\/content\/10.1101\/2019.12.18.881086v1.full.","DOI":"10.1101\/2019.12.18.881086"},{"key":"921_CR61","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.cell.2013.03.021","volume":"153","author":"SC Baca","year":"2013","unstructured":"Baca SC, Prandi D, Lawrence MS, Mosquera JM, Romanel A, Drier Y, et al. Punctuated evolution of prostate cancer genomes. Cell 2013;153:666\u201377.","journal-title":"Cell"},{"key":"921_CR62","first-page":"3974","volume":"58","author":"GA Pihan","year":"1998","unstructured":"Pihan GA, Purohit A, Wallace J, Knecht H, Woda B, Quesenberry P, et al. Centrosome defects and genetic instability in malignant tumors. Cancer Res 1998;58:3974\u201385.","journal-title":"Cancer Res"},{"key":"921_CR63","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/nrc924","volume":"2","author":"EA Nigg","year":"2002","unstructured":"Nigg EA. Centrosome aberrations: cause or consequence of cancer progression? Nat Rev Cancer. 2002;2:815.","journal-title":"Nat Rev Cancer"},{"key":"921_CR64","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1083\/jcb.200403014","volume":"165","author":"Y Uetake","year":"2004","unstructured":"Uetake Y, Sluder G. Cell cycle progression after cleavage failure: mammalian somatic cells do not possess a \u201ctetraploidy checkpoint\u201d. J Cell Biol. 2004;165:609\u201315.","journal-title":"J Cell Biol"},{"key":"921_CR65","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1126\/science.1104905","volume":"307","author":"NJ Quintyne","year":"2005","unstructured":"Quintyne NJ, Reing JE, Hoffelder DR, Gollin SM, Saunders WS. Spindle multipolarity is prevented by centrosomal clustering. Science. 2005;307:127\u20139.","journal-title":"Science"},{"key":"921_CR66","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.1182\/blood-2005-09-3810","volume":"107","author":"WJ Chng","year":"2006","unstructured":"Chng WJ, Ahmann GJ, Henderson K, Santana-Davila R, Greipp PR, Gertz MA, et al. Clinical implication of centrosome amplification in plasma cell neoplasm. Blood. 2006;107:3669\u201375.","journal-title":"Blood."},{"key":"921_CR67","doi-asserted-by":"crossref","first-page":"6175","DOI":"10.1038\/sj.onc.1205775","volume":"21","author":"S Dutertre","year":"2002","unstructured":"Dutertre S, Descamps S, Prigent C. On the role of aurora-A in centrosome function. Oncogene. 2002;21:6175.","journal-title":"Oncogene."},{"key":"921_CR68","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.1182\/blood-2006-07-037671","volume":"109","author":"Y Shi","year":"2007","unstructured":"Shi Y, Reiman T, Li W, Maxwell CA, Sen S, Pilarski L, et al. Targeting aurora kinases as therapy in multiple myeloma. Blood. 2007;109:3915\u201321.","journal-title":"Blood."},{"key":"921_CR69","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/nrm1245","volume":"4","author":"M Carmena","year":"2003","unstructured":"Carmena M, Earnshaw WC. The cellular geography of Aurora kinases. Nat Rev Mol Cell Biol. 2003;4:842.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"921_CR70","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/2496","volume":"20","author":"H Zhou","year":"1998","unstructured":"Zhou H, Kuang J, Zhong L, Kuo W-L, Gray J, Sahin A, et al. Tumour amplified kinase STK15\/BTAK induces centrosome amplification, aneuploidy and transformation. Nat Genet. 1998;20:189.","journal-title":"Nat Genet."},{"key":"921_CR71","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.1182\/blood-2008-09-178350","volume":"113","author":"D Hose","year":"2009","unstructured":"Hose D, Reme T, Meissner T, Moreaux J, Seckinger A, Lewis J, et al. Inhibition of aurora kinases for tailored risk-adapted treatment of multiple myeloma. Blood. 2009;113:4331\u201340.","journal-title":"Blood."},{"key":"921_CR72","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1182\/blood-2006-07-038430","volume":"109","author":"JD Shaughnessy Jr.","year":"2007","unstructured":"Shaughnessy JD,Jr., Zhan F, Burington BE, Huang Y, Colla S, Hanamura I, et al. A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1. Blood. 2007;109:2276\u201384.","journal-title":"Blood."},{"key":"921_CR73","doi-asserted-by":"crossref","first-page":"R285","DOI":"10.1016\/j.cub.2010.01.034","volume":"20","author":"SL Thompson","year":"2010","unstructured":"Thompson SL, Bakhoum SF, Compton DA. Mechanisms of chromosomal instability. Curr Biol. 2010;20:R285\u201395.","journal-title":"Curr Biol"},{"key":"921_CR74","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1182\/blood-2005-01-0034","volume":"106","author":"PL Bergsagel","year":"2005","unstructured":"Bergsagel PL, Kuehl WM, Zhan F, Sawyer J, Barlogie B, Shaughnessy J,Jr. Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma. Blood. 2005;106:296\u2013303.","journal-title":"Blood."},{"key":"921_CR75","first-page":"3505","volume":"59","author":"M Kornmann","year":"1999","unstructured":"Kornmann M, Danenberg KD, Arber N, Beger HG, Danenberg PV, Korc M. Inhibition of cyclin D1 expression in human pancreatic cancer cells is associated with increased chemosensitivity and decreased expression of multiple chemoresistance genes. Cancer Res. 1999;59:3505\u201311.","journal-title":"Cancer Res"},{"key":"921_CR76","doi-asserted-by":"crossref","first-page":"224","DOI":"10.18632\/oncotarget.476","volume":"3","author":"MC Casimiro","year":"2012","unstructured":"Casimiro MC, Pestell RG. Cyclin d1 induces chromosomal instability. Oncotarget. 2012;3:224\u201345.","journal-title":"Oncotarget."},{"key":"921_CR77","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/ajh.24094","volume":"90","author":"JM Vose","year":"2015","unstructured":"Vose JM. Mantle cell lymphoma: 2015 update on diagnosis, risk-stratification, and clinical management. Am J Hematol. 2015;90:739\u201345.","journal-title":"Am J Hematol"},{"key":"921_CR78","doi-asserted-by":"crossref","first-page":"38083","DOI":"10.1074\/jbc.274.53.38083","volume":"274","author":"HI Saavedra","year":"1999","unstructured":"Saavedra HI, Fukasawa K, Conn CW, Stambrook PJ. MAPK mediates RAS-induced chromosome instability. J Biol Chem. 1999;274:38083\u201390.","journal-title":"J Biol Chem"},{"key":"921_CR79","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/jcb.23400","volume":"113","author":"W Hanel","year":"2012","unstructured":"Hanel W, Moll UM. Links between mutant p53 and genomic instability. J Cell Biochem. 2012;113:433\u20139.","journal-title":"J Cell Biochem"},{"key":"921_CR80","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1172\/JCI60256","volume":"122","author":"MC Casimiro","year":"2012","unstructured":"Casimiro MC, Crosariol M, Loro E, Ertel A, Yu Z, Dampier W, et al. ChIP sequencing of cyclin D1 reveals a transcriptional role in chromosomal instability in mice. J Clin Investig. 2012;122:833\u201343.","journal-title":"J Clin Investig"},{"key":"921_CR81","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2017.19","volume":"7","author":"A Rossi","year":"2017","unstructured":"Rossi A, Voigtlaender M, Janjetovic S, Thiele B, Alawi M, Marz M, et al. Mutational landscape reflects the biological continuum of plasma cell dyscrasias. Blood Cancer J. 2017;7:e537.","journal-title":"Blood Cancer J"},{"key":"921_CR82","first-page":"5754","volume":"56","author":"TY Reynolds","year":"1996","unstructured":"Reynolds TY, Rockwell S, Glazer PM. Genetic instability induced by the tumor microenvironment. Cancer Res. 1996;56:5754\u20137.","journal-title":"Cancer Res"},{"key":"921_CR83","first-page":"428","volume":"61","author":"CY Li","year":"2001","unstructured":"Li CY, Little JB, Hu K, Zhang W, Zhang L, Dewhirst MW, et al. Persistent genetic instability in cancer cells induced by non-DNA-damaging stress exposures. Cancer Res 2001;61:428\u201332.","journal-title":"Cancer Res"},{"key":"921_CR84","first-page":"3173","volume":"54","author":"B Paquette","year":"1994","unstructured":"Paquette B, Little JB. In vivo enhancement of genomic instability in minisatellite sequences of mouse C3H\/10T1\/2 cells transformed in vitro by X-rays. Cancer Res. 1994;54:3173\u20138.","journal-title":"Cancer Res"},{"key":"921_CR85","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/wsbm.69","volume":"2","author":"GL Semenza","year":"2010","unstructured":"Semenza GL. Oxygen homeostasis. Wiley Interdiscip Rev Syst Biol Med. 2010;2:336\u201361.","journal-title":"Wiley Interdiscip Rev Syst Biol Med"},{"key":"921_CR86","doi-asserted-by":"crossref","first-page":"5782","DOI":"10.1182\/blood-2011-09-380410","volume":"119","author":"AK Azab","year":"2012","unstructured":"Azab AK, Hu J, Quang P, Azab F, Pitsillides C, Awwad R, et al. Hypoxia promotes dissemination of multiple myeloma through acquisition of epithelial to mesenchymal transition-like features. Blood. 2012;119:5782\u201394.","journal-title":"Blood."},{"key":"921_CR87","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.mrfmmm.2004.03.013","volume":"569","author":"RS Bindra","year":"2005","unstructured":"Bindra RS, Glazer PM. Genetic instability and the tumor microenvironment: towards the concept of microenvironment-induced mutagenesis. Mutat Res. 2005;569:75\u201385.","journal-title":"Mutat Res."},{"key":"921_CR88","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1038\/leu.2011.327","volume":"26","author":"O Meynet","year":"2011","unstructured":"Meynet O, B\u00e9n\u00e9teau M, Jacquin MA, Pradelli LA, Cornille A, Carles M, et al. Glycolysis inhibition targets Mcl-1 to restore sensitivity of lymphoma cells to ABT-737-induced apoptosis. Leukemia. 2011;26:1145.","journal-title":"Leukemia."},{"key":"921_CR89","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/bjc.2012.527","volume":"108","author":"S Fujiwara","year":"2013","unstructured":"Fujiwara S, Kawano Y, Yuki H, Okuno Y, Nosaka K, Mitsuya H. et al. PDK1 inhibition is a novel therapeutic target in multiple myeloma. Br J Cancer. 2013;108:170\u20138.","journal-title":"Br J Cancer"},{"key":"921_CR90","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.1073\/pnas.78.6.3673","volume":"78","author":"A Varshavsky","year":"1981","unstructured":"Varshavsky A. On the possibility of metabolic control of replicon \u201cmisfiring\u201d: relationship to emergence of malignant phenotypes in mammalian cell lineages. Proc Natl Acad Sci USA. 1981;78:3673.","journal-title":"Proc Natl Acad Sci USA"},{"key":"921_CR91","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-05058-y","volume":"9","author":"N Bolli","year":"2018","unstructured":"Bolli N, Maura F, Minvielle S, Gloznik D, Szalat R, Fullam A, et al. Genomic patterns of progression in smoldering multiple myeloma. Nat Commun. 2018;9:3363.","journal-title":"Nat Commun."},{"key":"921_CR92","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nature12213","volume":"499","author":"MS Lawrence","year":"2013","unstructured":"Lawrence MS, Stojanov P, Polak P, Kryukov GV, Cibulskis K, Sivachenko A, et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature. 2013;499:214.","journal-title":"Nature."},{"key":"921_CR93","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/s41591-019-0382-x","volume":"25","author":"TE Keenan","year":"2019","unstructured":"Keenan TE, Burke KP, Van Allen EM. Genomic correlates of response to immune checkpoint blockade. Nat Med. 2019;25:389\u2013402.","journal-title":"Nat Med"},{"key":"921_CR94","doi-asserted-by":"crossref","first-page":"4065","DOI":"10.1182\/bloodadvances.2019001012","volume":"3","author":"K Wienand","year":"2019","unstructured":"Wienand K, Chapuy B, Stewart C, Dunford AJ, Wu D, Kim J, et al. Genomic analyses of flow-sorted Hodgkin Reed-Sternberg cells reveal complementary mechanisms of immune evasion. Blood Adv. 2019;3:4065\u201380.","journal-title":"Blood Adv"},{"key":"921_CR95","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1182\/blood.2019002067","volume":"134","author":"B Chapuy","year":"2019","unstructured":"Chapuy B, Stewart C, Dunford AJ, Kim J, Wienand K, Kamburov A, et al. Genomic analyses of PMBL reveal new drivers and mechanisms of sensitivity to PD-1 blockade. Blood. 2019;134:2369\u201382.","journal-title":"Blood"},{"key":"921_CR96","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nature12477","volume":"500","author":"LB Alexandrov","year":"2013","unstructured":"Alexandrov LB, Nik-Zainal S, Wedge DC, Aparicio SA, Behjati S, Biankin AV, et al. Signatures of mutational processes in human cancer. Nature. 2013;500:415\u201321.","journal-title":"Nature"},{"key":"921_CR97","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.cell.2012.04.024","volume":"149","author":"S Nik-Zainal","year":"2012","unstructured":"Nik-Zainal S, Alexandrov LB, Wedge DC, Van Loo P, Greenman CD, Raine K, et al. Mutational processes molding the genomes of 21 breast cancers. Cell. 2012;149:979\u201393.","journal-title":"Cell."},{"key":"921_CR98","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/leu.2017.345","volume":"32","author":"F Maura","year":"2018","unstructured":"Maura F, Petljak M, Lionetti M, Cifola I, Liang W, Pinatel E, et al. Biological and prognostic impact of APOBEC-induced mutations in the spectrum of plasma cell dyscrasias and multiple myeloma cell lines. Leukemia. 2018;32:1043\u20137.","journal-title":"Leukemia"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41375-020-0921-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41375-020-0921-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41375-020-0921-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:41:07Z","timestamp":1684618867000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-020-0921-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,10]]},"references-count":98,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["921"],"URL":"https:\/\/doi.org\/10.1038\/s41375-020-0921-y","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,10]]},"assertion":[{"value":"16 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"There was no commercial funding for this review. MB has advisory role and received Honoraria from Takeda and has received honoraria Dava Oncology. IMG has a consulting and advisory role with Celgene, Takeda, Bristol-Myers Squibb, Genentech, Janssen Pharmaceuticals, and Amgen, and has received research funding\/honoraria from Celgene, Takeda, Bristol-Myers Squibb, Janssen Pharmaceuticals, and Amgen. The rest of the authors have no conflicts to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}